John F. Kober III, an officer of MACOM Technology Solutions Holdings, Inc., filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 21,036 shares of common stock acquired through Performance Stock Units.
SPS Commerce officer Jamie J. Thingelstad filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 11,196 shares of SPS Commerce, Inc. common stock acquired through the exercise of options under a registered plan.
Incyte Corporation officer Steven Stein filed a Form 144 notice of proposed sale on November 6, 2026, covering 240,193 shares of Incyte common stock to be sold through Morgan Stanley Smith Barney LLC.
Grab Holdings Limited director and officer Anthony Ping Yeow Tan filed a Form 144 on November 6, 2026, disclosing a proposed sale of 1,200,000 Class A ordinary shares of Grab Holdings Limited on NASDAQ under the symbol GRAB.
Madrigal Pharmaceuticals, Inc. officer Shannon Kelley filed a Form 144 notice of proposed sale of 1,077 shares of common stock, dated November 6, 2026, through Morgan Stanley Smith Barney LLC Executive Financial Services.
Remitly Global, Inc. director Joshua D. Hug filed a Form 144 notice of proposed sale on November 6, 2026, covering 5,500 shares of common stock to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services under a 10b5-1 trading plan.
Eagle Bancorp, Inc. director A. Leslie Ludwig filed a Form 144 notice of proposed sale of 14,669 shares of Eagle Bancorp common stock, with a notice date of November 6, 2026, through broker Morgan Stanley Smith Barney LLC Executive Financial Services.
Ann M. Kappler, an officer of Prudential Financial Inc, filed a Form 144 notice on November 6, 2026, proposing the sale of 2,919 shares of Prudential Financial common stock through broker Morgan Stanley Smith Barney LLC.
Andrew F. Sullivan, Chief Executive Officer and Chairman of the Board of Prudential Financial Inc., filed a Form 144 notice of proposed sale of 3,705 common shares on November 6, 2026, arising from the exercise of stock options granted in 2017.
J. Jefferson Smith, an officer of Precision Biosciences Inc, filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 875 shares of common stock on NASDAQ under Rule 144 of the Securities Act of 1933.